SCHEMBL6408489

SCHEMBL6408489

N[C@H]1CC[C@@](O)(Cl)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408493 1.00
SCHEMBL4069109 0.75
SCHEMBL6034292 0.75 OPRL1 (0.32)
SCHEMBL774748 0.73
SCHEMBL384447 0.71
SCHEMBL567069 0.71
SCHEMBL384448 0.71
SCHEMBL12577355 0.70
Hydrochloric Acid SCHEMBL12494114 0.69 ESR2 (0.39)
Hydrochloric Acid SCHEMBL1693713 0.69 ESR2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005092896-A1 COMPOUND FOR INHIBITING TYROSINE KINASE ACTIVITY OF DDR2 PROTEIN KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2005-10-06 WO disclosed
US-6608058-B2 Therapeutic composition for hepatitis B, hepatitis C, or acquired immune deficiency syndrome DONG WHA PHARM. IND. CO., LTD. (KR) 2003-08-19 US disclosed
US-20030092709-A1 6-Methylnicotinamide derivatives as antiviral agents DONG WHA PHARM. CO., LTD. (KR) 2003-05-15 US disclosed
WO-2001078648-A2 6-METHYLNICOTINAMIDE DERIVATIVES AS ANTIVIRAL AGENTS DONG WHA PHARM. IND. CO., LTD. (KR) 2001-10-25 WO disclosed